← Back to Search

Nonsteroidal Anti-inflammatory Drug (NSAID)

Topical, intra-oral ketoprofen gel for Migraine

Phase 3
Waitlist Available
Led By Caren Behar, MD
Research Sponsored by Behar, Caren, M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 240 minutes post-treatment
Awards & highlights

Study Summary

The purpose of this study is to evaluate the efficacy and safety of intra-oral topical ketoprofen for the treatment of acute migraine.

Eligible Conditions
  • Migraine

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 240 minutes post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 240 minutes post-treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain relief (defined as at least 2 graded reduction in a 5-grade scale) at 120 minutes post-treatment
Secondary outcome measures
Need for Rescue Medication between the time of dosing to 240 minutes
Pain free status at 30, 60, 120, and 240 minutes post-treatment based on headache severities reported in patient's journals
Pain relief at 30, 60, and 240 minutes post-treatment based on headache severities reported in patient's journals
+4 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Topical, intra-oral ketoprofen gelActive Control1 Intervention
Group II: Placebo gelPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Behar, Caren, M.D.Lead Sponsor
1 Previous Clinical Trials
67 Total Patients Enrolled
1 Trials studying Migraine
67 Patients Enrolled for Migraine
Caren Behar, MDPrincipal InvestigatorNew York Medical College
1 Previous Clinical Trials
67 Total Patients Enrolled
1 Trials studying Migraine
67 Patients Enrolled for Migraine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine
2011. "The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01228552.
All > Migraine
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top